Cayston

Cayston is an inhaled antibiotic solution used to treat respiratory infections in patients with cystic fibrosis. It contains aztreonam, a monobactam antibiotic, and is administered via nebulization. This medication is designed to target specific bacteria that commonly affect the lungs of cystic fibrosis patients.

Cayston is primarily used for the management of respiratory infections caused by Pseudomonas aeruginosa in individuals with cystic fibrosis. This medication is specifically formulated for inhalation, allowing it to directly target the bacteria in the lungs. Patients often wonder, 'What is Cayston used for?' It is intended for those who have difficulty clearing mucus and are at risk of lung infections.

Common effects of Cayston may include coughing, wheezing, or throat irritation during or after inhalation. Some users may experience a bad taste in the mouth or mild headache. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Cayston should be used under the guidance of a healthcare professional. It is important to follow the prescribed dosage and administration instructions carefully. Patients with a history of severe allergic reactions to aztreonam or other beta-lactam antibiotics should exercise caution. Always inform your healthcare provider about any other medications you are taking.

Cayston may interact with other medications, particularly those that affect lung function or immune response. It is important to discuss all current medications with a healthcare provider before starting Cayston. Avoid using other inhaled medications simultaneously without consulting a healthcare professional to prevent potential interactions.